DeviceTalks Archives - Page 3 of 5 - Medical Design Sourcing

DeviceTalks Boston early-bird rate expires tomorrow

The early-bird registration discount for DeviceTalks Boston ends tomorrow, March 9.

Register right away to save $300 off (43%) off the full price to attend the May 10-11 event at the Boston Convention & Exhibition Center.

Discussions will focus on engineering new devices, materials and manufacturing, bringing products to market, and other challenges to medical device development.

Large medical device companies leading presentations include Abbott, Becton Dickinson, Boston Scientific, Medtronic, Smith & Nephew, Stryker, Olympus, Philips, Vicarious Surgical, Zimmer Biomet, ZimVie, and other medical device companies.

The event features keynotes from Mike Mahoney, CEO of Boston Scientific, and Tom Polen, CEO of BD.

Medtech Innovator will bring a group of start-ups that have graduated from its accelerator to tell their stories.

Go to Boston.DeviceTalks.com to register.

DeviceTalks Boston early bird pricing expires next week

Medical device professionals eager to expand their skillsets and build their brand have until March 9 to secure the early-bird rate to register for DeviceTalks Boston.

The rate will jump from $395 to $695 where it will stay until the day of the May 10-11 conference, which will be held at the Boston Convention & Exhibition Center.

DeviceTalks Boston promises to deliver two days of networking, content and know-how for medical device entrepreneurs, engineers, and executives.

The agenda will feature executives and professionals from more than a dozen major medical device companies including Abbott, BD, Boston Scientific, Medtronic, Olympus America Corp., Philips, Smith & Nephew, Stryker, Vicarious Surgical, ZimVie Spine, Zimmer Biomet and more.

Medtech Innovator, the industry’s largest accelerator, will also host a two-day long track featuring its most successful alumni.

Go here to see the agenda and view the list of speakers including …

How these engineers make DeviceTalks Boston go!

We love engineers of all types — here are a just a few you’ll meet at DeviceTalks Boston.

We love engineers here at DeviceTalks.

It’s obvious why. Engineers are the straw that stirs medtech’s drink (apologies to Reggie Jackson). Nothing happens — financing, manufacturing, approval, help for patients — without a well-conceived product.

And engineers often transcend their typical design roles. They grow into business leaders, technology evangelists, startup CEOs, and yes, some stay to lead ground-breaking research and development groups.

So I’m thrilled to be bringing engineers of all types into the agenda of DeviceTalks Boston. We’ll have engineers from Abbott, ZimVie, Philips, Boston Scientific, Stryker and many other companies on hand to talk about being an engineer.

But we’ll also hear from engineers who have followed their careers into other parts of the medical device industry.

In this column, we’ll walk you through some of their …

How these engineers make DeviceTalks Boston go!

We love engineers here at DeviceTalks.

It’s obvious why. Engineers are the straw that stirs medtech’s drink (apologies to Reggie Jackson). Nothing happens — financing, manufacturing, approval, help for patients — without a well-conceived product.

And engineers often transcend their typical design roles. They grow into business leaders, technology evangelists, startup CEOs, and yes, some stay to lead ground-breaking research and development groups.

So I’m thrilled to be bringing engineers of all types into the agenda of DeviceTalks Boston. We’ll have engineers from Abbott, ZimVie, Philips, Boston Scientific, Stryker and many other companies on hand to talk about being an engineer.

But we’ll also hear from engineers who have followed their careers into other parts of the medical device industry.

In this column, we’ll walk you through some of their career highlights as told in interviews on our DeviceTalks Weekly podcast. We’ll explain t…

5 tips from medtech leaders for the next generation

Mike Mahoney is chair and CEO of Boston Scientific. [Photo courtesy of Boston Scientific]

When interviewing senior executives on our DeviceTalks podcasts I always start by asking how they got into medtech.

Starting at career square one allows us to walk through the decisions that led to their success. I like to spend a few minutes examining those critical crossroad moments when the guests chose to leap into a new opportunity.

These interviews are full of lessons and tips for younger medtech professionals to equip themselves with experience and insights that will help develop them into leaders of the future.

RELATED: Move over baby boomers, former Medtronic CEO Bill George says

You’ll need to listen to our past episodes for every bit of great advice. But we pulled these particularly helpful tidbits to help you build your successful career.

Tip 1: Run to the fire

Michael Mahoney surpri…

DeviceTalks Weekly: What’s your top story of 2022?

DeviceTalks Weekly is inviting listeners to record their personal picks for top medtech story of 2022. It’s easy!

Step 1 — Make sure you’re on a device with a good microphone. Phones work great! Step 2 — Click here. This will open a new window.

Step 3 — Open up by giving us you name, company or other affiliation. Please include your email just in case we have a question. Step 4 — Take one minute to record your top Newsmaker and why. If you trip up start over. No problem. Step 5 — Listen to next week’s DeviceTalks Weekly!

We’d really love to hear from our DeviceTalks community about the big stories that have impacted their lives!

DeviceTalks Weekly and MassDevice have covered so much important news over the past year: the massive Philips respiratory devices recall, J&J’s Abiomed acquisition, a potential MDR deadline extension, a hot surgical robotics space, and much more. But what are we missing?

This is y…

Device developers get creative to connect with physicians

Dr. Farzad Azimpour is SVP of Advanced Technology at Edwards Lifesciences [Photo courtesy of Edwards Lifesciences]

Medical device developers have gotten creative in connecting with surgeons and interventionalists during the pandemic.

Leaders from Abbott, Boston Scientific and Edwards Lifesciences shared some of their experiences, challenges and opportunities with attendees of DeviceTalks West in October.

The chief challenge is the number of physicians, nurses and other medical professionals who have left the field during the pandemic.

“The elephant in the room is that everybody is worried about how we’re going to get things to patients,” said Farzad Azimpour, SVP of Advanced Technology at Edwards Lifesciences. “How do we equip the limited capacity that we have right now — from nursing, physicians, everyone — to enable what we have to actually reach patients in a timely and appropriate manner…

How Johnson & Johnson is looking to lead the way in ablation

“If you want to go fast, go alone. If you want to go forward, go together,” Johnson & Johnson’s Celine Martin (left) said of innovation during a DeviceTalks West 2022 keynote interview with MassDevice executive editor Chris Newmarker (right). [Image by Kara Singleton, WTWH Media]Celine Martin, Johnson & Johnson group chair, cardiovascular & specialty solutions (CSS) group, oversees high-growth areas at the company’s global MedTech business.

Her leadership covers Acclarent, Biosense Webster, Cerenovus and Mentor. Together, those companies bring in more than $5 billion in annual sales with more than 14,000 employees.

Over 25 years at Johnson & Johnson, Martin has looked to improve standards of care for AFib, stroke and minimally invasive surgery. At DeviceTalks West in Santa Clara last week, she spoke in a keynote address about how she’s done it.

On treating AFib at Biosense Webster

Martin said at DeviceTalks that…

Medtronic unveils new neurovascular innovation incubator program

Dan Volz (right) and Derek Crittenden (left) present the Medtronic Co-Lab program at DeviceTalks West in Santa Clara, California.

Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space.

In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy program manager, presented the news.

“We’re pleased to share with you today the Medtronic neurovascular Co-Lab platform,” Volz said. “This is a community platform designed to transform ideas and technologies into novel global therapies by providing physicians and entrepreneurs with insight with support, and most importantly, making sure innovation has the chance to touch as many people around the world as possibl…

How medical device companies can better protect themselves from lawsuits

Getting hit with lawsuits isn’t an if, but a when for medical device developers and manufacturers. A veteran Greenberg Traurig lawyer shares advice for staying secure.

[Image from Pixabay]

As with pharmaceutical companies and health providers, medtech is emerging from the COVID-19 pandemic with a great deal of goodwill, says Ginger Pigott, a Greenberg Traurig shareholder. Pigott has seen the industry’s improved image helping device companies with juries, mock juries and the litigation process in general.

But don’t bet on the trend lasting.

“I’ve been practicing for 30 years, and it goes in that cycle all the time,” Pigott said in a recent interview with Medical Design & Outsourcing. (Pigott will moderate a panel about building startups to last at DeviceTalks West, Oct. 19-20, 2022 in Santa Clara, California.)

In fact, Pigott suspects the present economic unc…

September 2022 Issue: The Medtech Big 100 is bigger than ever

Medtech sales reach a record high as R&D spend and employee counts climb

Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future

Autotransfusion device maker ships units to Ukraine

How IP protection is enabling robotic surgery innovation

Connected device design for the real world: Managing the development process

FDA details plans to expand remote safety assessments for device makers

Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye

The Medtech Big 100 is bigger than ever

The tide has turned.

The Medtech Big 100 — Medical Design & Outsourcing‘s annual revenue ranking of the world’s …

Join us at DeviceTalks West, the World’s Fair of Medtech

Intuitive Surgical CEO Gary Guthart will participate in a keynote interview at DeviceTalks West 2022. [Photo courtesy of Intuitive Surgical]

October’s DeviceTalks West conference is focused on the future.

The best-seller “Devil in the White City” may have darkened the perception of world’s fairs, but these international convocations have long presented visitors with an optimistic and hopeful view of the future, thanks in no small part to new technology. (The next one is scheduled for 2025 in Osaka, Japan, by the way.)

I like to think we’ll be following similar guidelines at the upcoming DeviceTalks West conference, which will be held on Oct. 19-20 at the Santa Clara Convention Center.

This event will bring together executives from Abbott, Boston Scientific, Edwards Lifesciences, Intuitive, Johnson & Johnson, Medtronic, Outset Medical, Penumbra, Shockwave, Zimmer Biomet and many …